Ascentage Pharma Group International (AAPG) Inventory Average (2024 - 2025)
Ascentage Pharma Group International (AAPG) posted quarterly Inventory Average of $2.6 million for Q4 2025, up 65.43% year-on-year from $1.6 million in Q4 2024, and up 147.19% on a QoQ basis from $1.1 million in Q2 2025.
Ascentage Pharma Group International (AAPG) Inventory Average (2024 - 2025) Analysis & Trends
Ascentage Pharma Group International (AAPG) has reported Inventory Average for 2 consecutive years, with $2.6 million the latest figure, recorded in Q4 2025.
- Quarterly Inventory Average rose 65.43% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (up 65.43% YoY) and the FY2025 annual result came in at $2.5 million, up 56.53% from the prior year.
- Inventory Average advanced to $2.6 million in Q4 2025 per AAPG's latest filing, from $1.1 million in the prior quarter.
- Over the last five years, Inventory Average for AAPG reached as high as $2.6 million in Q4 2025 and fell as low as $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascentage Pharma Group International | 6.88 Bn | 6.54 Bn | - | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.62 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.58 Mn |